Peer Reviewed
Feature Article Paediatrics
Management of wheezy infants and preschool children
Abstract
This second article in a two-part series on wheeze in children focuses on the management of the more common causes in infants (aged under 1 year) and preschool children (aged 1 to 4 years) using the best available published evidence.
Key Points
- Most wheezy infants have acute bronchiolitis or transient early wheezing, neither of which generally warrants any specific therapy.
- Age has a significant bearing on the patient’s response to inhaled bronchodilators.
- Bronchodilators should not be used routinely for first-time wheezy infants with presumed acute viral bronchiolitis.
- Toddlers with wheezing associated respiratory infection (WARI) should be given a trial of inhaled bronchodilator as required.
- Infants and preschool children with persistent or frequently recurrent wheezing deserve a trial of long term preventive therapy with inhaled corticosteroids or a nonsteroidal preventer.
Purchase the PDF version of this article
Already a subscriber? Login here.